- Home
- EURK vs AVTX Comparison
EURK vs AVTX Comparison
Compare EURK & AVTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EURK
- AVTX
- Stock Information
- Founded
- EURK 2023
- AVTX 2011
- Country
- EURK Cayman Islands
- AVTX United States
- Employees
- EURK N/A
- AVTX N/A
- Industry
- EURK
- AVTX Biotechnology: Pharmaceutical Preparations
- Sector
- EURK
- AVTX Health Care
- Exchange
- EURK NYSE
- AVTX Nasdaq
- Market Cap
- EURK 77.4M
- AVTX 90.9M
- IPO Year
- EURK 2024
- AVTX 2015
- Fundamental
- Price
- EURK $10.15
- AVTX $9.38
- Analyst Decision
- EURK
- AVTX Buy
- Analyst Count
- EURK 0
- AVTX 3
- Target Price
- EURK N/A
- AVTX $29.50
- AVG Volume (30 Days)
- EURK 51.9K
- AVTX 90.5K
- Earning Date
- EURK 01-01-0001
- AVTX 11-07-2024
- Dividend Yield
- EURK N/A
- AVTX N/A
- EPS Growth
- EURK N/A
- AVTX N/A
- EPS
- EURK N/A
- AVTX N/A
- Revenue
- EURK N/A
- AVTX $820,000.00
- Revenue This Year
- EURK N/A
- AVTX N/A
- Revenue Next Year
- EURK N/A
- AVTX N/A
- P/E Ratio
- EURK N/A
- AVTX N/A
- Revenue Growth
- EURK N/A
- AVTX N/A
- 52 Week Low
- EURK $10.03
- AVTX $3.95
- 52 Week High
- EURK $10.16
- AVTX $34.46
- Technical
- Relative Strength Index (RSI)
- EURK N/A
- AVTX 42.72
- Support Level
- EURK N/A
- AVTX $9.00
- Resistance Level
- EURK N/A
- AVTX $9.82
- Average True Range (ATR)
- EURK 0.00
- AVTX 0.75
- MACD
- EURK 0.00
- AVTX 0.01
- Stochastic Oscillator
- EURK 0.00
- AVTX 27.86
About EURK EUREKA ACQUISITION CORP
Eureka Acquisition Corp is a newly incorporated blank check company.
About AVTX Avalo Therapeutics Inc.
Avalo Therapeutics Inc is a clinical stage biotechnology company focused on the treatment of immune dysregulation. The company's lead asset is AVTX-009, an anti-IL-1B monoclonal antibody ("mAb"), targeting inflammatory diseases. Avalo's pipeline also includes quisovalimab (anti-LIGHT mAb) and AVTX-008 (BTLA agonist fusion protein).